177 related articles for article (PubMed ID: 21287668)
1. Eruptive benign melanocytic naevi during immunosuppressive therapy in a Crohn's disease patient.
de Boer NK; Kuyvenhoven JP
Inflamm Bowel Dis; 2011 Jun; 17(6):E26. PubMed ID: 21287668
[No Abstract] [Full Text] [Related]
2. Spot diagnosis: eruptive melanocytic naevi during azathioprine therapy in Crohn's disease.
Wonders J; De Boer NK; Van Weyenberg SJ
J Crohns Colitis; 2012 Jun; 6(5):636. PubMed ID: 22402255
[No Abstract] [Full Text] [Related]
3. Sudden onset of Multiple nevi after administration of 6-mercaptopurine in an adult with Crohn's disease: a case report.
Kakrida M; Orengo I; Markus R
Int J Dermatol; 2005 Apr; 44(4):334-6. PubMed ID: 15811090
[TBL] [Abstract][Full Text] [Related]
4. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals.
Bovenschen HJ; Tjioe M; Vermaat H; de Hoop D; Witteman BM; Janssens RW; Stoof TJ; van de Kerkhof PC
Br J Dermatol; 2006 May; 154(5):880-4. PubMed ID: 16634890
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence?
Katsanos KH; Christodoulou DK; Zioga A; Tsianos EV
Inflamm Bowel Dis; 2003 Jul; 9(4):279. PubMed ID: 12902853
[No Abstract] [Full Text] [Related]
6. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease.
Thayu M; Markowitz JE; Mamula P; Russo PA; Muinos WI; Baldassano RN
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):220-2. PubMed ID: 15699701
[No Abstract] [Full Text] [Related]
7. Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease.
Belloni Fortina A; Piaserico S; Zattra E; Alaibac M
Melanoma Res; 2005 Jun; 15(3):223-4. PubMed ID: 15917707
[TBL] [Abstract][Full Text] [Related]
8. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].
Bastida Paz G; Nos Mateu P; Aguas Peris M; Beltrán Niclós B; Rodríguez Soler M; Ponce García J
Gastroenterol Hepatol; 2007 Nov; 30(9):511-6. PubMed ID: 17980127
[TBL] [Abstract][Full Text] [Related]
9. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Ruffolo C; Scarpa M; Bassi N
N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
[No Abstract] [Full Text] [Related]
10. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
Schreiber S
Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
[No Abstract] [Full Text] [Related]
11. Demyelination-like syndrome in Crohn's disease after infliximab therapy.
Freeman HJ; Flak B
Can J Gastroenterol; 2005 May; 19(5):313-6. PubMed ID: 15915246
[TBL] [Abstract][Full Text] [Related]
12. Eruptive nevi associated with medications (ENAMs).
Perry BM; Nguyen A; Desmond BL; Blattner CM; Thomas RS; Young RJ
J Am Acad Dermatol; 2016 Nov; 75(5):1045-1052. PubMed ID: 27241804
[TBL] [Abstract][Full Text] [Related]
13. Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
Abou Zahr A; Saad Aldin E; Yunyongying P
Int J Infect Dis; 2013 Aug; 17(8):e650-2. PubMed ID: 23769453
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced eruptive melanocytic nevi.
Vena GA; Fargnoli MC; Cassano N; Argenziano G
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):293-300. PubMed ID: 27759434
[TBL] [Abstract][Full Text] [Related]
15. Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine.
Lobel EZ; Korelitz BI; Vakher K; Panagopoulos G
Dig Dis Sci; 2004 Feb; 49(2):336-8. PubMed ID: 15104380
[No Abstract] [Full Text] [Related]
16. Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab.
Nancey S; Boschetti G; Cotte E; Cathey-Javouhay A; Laidet M; Chichery A; Francois Y; Glehen O; Flourié B
Inflamm Bowel Dis; 2011 Apr; 17(4):1060-1. PubMed ID: 21391289
[No Abstract] [Full Text] [Related]
17. Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.
Persley K; Scherl E; Rubin P
Am J Gastroenterol; 2001 Dec; 96(12):3444-5. PubMed ID: 11774971
[No Abstract] [Full Text] [Related]
18. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
Hyams JS
Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
[No Abstract] [Full Text] [Related]
19. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
20. Nocardia pneumonia in a patient with Crohn's disease receiving 6-mercaptopurine and infliximab.
Saleemuddin A; Govender P; Farraye FA
J Crohns Colitis; 2014 Jul; 8(7):708-9. PubMed ID: 24342764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
